MedTrace Logo

Intrathecal Morphine for Unilateral Total Knee Arthroplasty

NCT03232957 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2021-05-24

No results posted yet for this study

Summary

This study evaluates postoperative numerical pain score and systemic opioid requirement within 48 hours for unilateral total knee arthroplasty. Comparing among 3 groups of intrathecal morphine; 0,50, 100 ug with multimodal analgesia.

Conditions

  • Primary Osteoarthritis of Knee Nos

Interventions

PROCEDURE

50 ug IT morphine

Spinal block with bupivacaine and intrathecal morphine 50 ug

PROCEDURE

100 ug IT morphine

Spinal block with bupivacaine and intrathecal morphine 100 ug

PROCEDURE

No IT morphine

Spinal block with bupivacaine and intrathecal morphine 0 ug

DRUG

Morphine

intrathecal morphine

DRUG

Bupivacaine

0.5 isobaric bupivacaine

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Suwimon Tangwiwat, MD · Siriraj Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2019-02-01
Completion
2019-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03232957 on ClinicalTrials.gov